1-Boc-3-N-(Pyridin-4-ylmethyl)-amino-pyrrolidine, 97.0%, 1g

CROTAMITON, 95%, 25g

4-(4-Methylpiperidin-1-yl)-3-nitrobenzoic acid, 95.0%, 1g

4,4,5,5-Tetramethyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-bicyclo[1.1.1]pentanyl]-1,3,2-dioxaborolane, 97%, 100mg

Nonafluorobutanesulphonic acid, 98.0%, 25g

Trifluoro(pyrrolidin-1-ium-1-ylmethyl)borate, 97.0%, 5g

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1-carboxylate, 95.0%, 250mg

Thalidomide-O-amido-C8-NH2 (TFA), 100mg

(5-Cyclopropyl-1,3-oxazol-4-yl)methanol, 97%, 2.5g

Bis(acetonitrile)palladium(II) chloride, 99.0%, 1g

Flacon à vis ROTILABO® verre brun, 20000 ml, GL 45, 1 pièce

3-Chlorothiophene, 98.0%, 25g

2-(2-methylphenyl)acetamide, 1g